INTRODUCTION AND OBJECTIVES: Frailty, defined as a measure of decreased physiologic reserve, is strongly associated with increased susceptibility to disability and poor outcomes. The purpose of this study was to describe the extent of frailty among patients with various urologic diagnoses and to explore whether or not frailty differed between patients who did and did not undergo urologic surgery.
METHODS: This is a prospective study of men and women ages 65 and older presenting to an academic non-oncologic urology practice between December 2015 and May 2016. Frailty was measured in individuals via the Timed Up and Go Test (TUGT) upon intake. Based on the TUGT, individuals were classified as not frail (¼10 sec), intermediately frail (11-14 sec) or frail (¼15 sec). The TUGT and other clinical data were abstracted from the electronic medical record using EPIC analytical software into an on-going database. TUGT values were reported overall, by urologic diagnosis, and according to whether or not they were associated with a urologic procedure.
RESULTS: There were 1089 unique individuals who presented to our practice and had a TUGT during the study period. Among these individuals, the mean age was 73.3 (AE6.3) years, 77.6% were male, 64.7% were white and the mean TUGT was 11.6 (AE6.0) seconds, with 30.0% and 15.2% classified as intermediately frail and frail, respectively. TUGT time (and hence frailty) increased linearly with increasing age (Figure) . TUGT values differed by urologic diagnosis ranging from 9.9 (AE3.0) seconds among individuals with general male urology diagnoses to 14.3 (AE11.9) seconds among individuals with urinary tract infections (UTIs). There were no statistically significant differences in TUGT values between individuals who did and did not undergo urologic surgery.
CONCLUSIONS: Frailty is common, increases with age, and varies based on urologic diagnosis among individuals presenting to an academic non-oncologic urology practice. Interestingly, frailty did not differ between individuals who did and did not undergo urologic surgery, suggesting that there is a potential opportunity to incorporate frailty into the perioperative decision-making process. Since frailty is prevalent among urologic patients and linked to poor outcomes, consideration of frailty in the surgical decision-making process is warranted and may improve outcomes. 
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INTRODUCTION AND OBJECTIVES:
The prevalence of frailty is expected to increase due to the worldwide ageing. However, little is known about the prevalence of frailty in urological cancer patients. The aim of this study is to investigate the useful frailty assessment tools for urological cancer patients in comparison with community-dwelling population.
METHODS: From August 2013 to March 2016, we evaluated 486 consecutive urological cancer patients in our hospital. Urological cancers included prostate cancer (PC, n¼226), bladder cancer (BC, n¼132), upper tract urothelial carcinoma (UTUC, n¼42), and renal cell carcinoma (RCC, n¼86). We retrospectively compared age and sex adjusted urological cancer patients and 2766 community-dwelling subjects who underwent frailty assessment including physical status (handgrip strength and gait speed), serum test (serum albumin and renal function), and mental status (exhaustion and depression). Gait speed was evaluated by timed get up and go test (TGUG). Independent factors that were significantly associated with tumor-bearing status were evaluated by multivariate regression analysis.
RESULTS: The number of pair-matched patients in PC, BC, UTUC, and RCC were 212, 130, 41, and 84. TGUG, handgrip strength, and serum albumin were significantly worse in all types of cancers than controls. Renal function was significantly better in PC, whereas it was worse in BC, UTUC, and RCC than controls. The number of patients with exhaustion or depression were significantly higher in PC. Multivariate regression analysis showed TGUG and serum albumin were significantly associated with tumor-bearing status.
CONCLUSIONS: Urological cancer patients were significantly frail compared with community-dwelling older adults. Our results provide a picture of the prevalence of frailty in urological patients. TGUG and serum albumin may be simple and useful tools for frailty assessment in urological cancer patients.
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